article thumbnail

STAT+: Oral ketamine tablets effective for treating depression, new study finds

STAT

In the Phase 2 trial, the results of which were detailed in Nature Medicine , patients who took extended release ketamine tablets at an 180mg dosage twice weekly showed a “statistically significant and clinically meaningful improvement in depressive symptoms” compared to a placebo. Other dosages saw less of an impact.

Dosage 295
article thumbnail

Rising demand for pediatric dosage forms requires reformulation, expertise, and to-scale manufacturing capabilities

Pharmaceutical Technology

Pharmaceutical companies are looking to paediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. Various modifications to adult dosage forms (ADFs) are often needed to make a drug easier for children to take and easier for parents to administer. Innovative solutions to complex challenges.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BENEO presents galenIQ for highly flowable and stable sachet powders

Pharma Mirror

To ensure accurate dosage and administration, the powders used in these delivery systems require excellent flowability. BENEO’s filler-binder galenIQ™ 721 meets this demand and helps formulators to develop more convenient dosage forms. Consumers appreciate their ease of use and the ability to take them without water.

Dosage 52
article thumbnail

Enforcement Trends: CDER Presentation Confirms Fewer Warning Letters Are Issued by FDA for OAI Inspections

FDA Law Blog: Biosimilars

Farquhar — At the GMP by the Sea Conference ongoing in Cambridge, Maryland, a presentation was made by a representative of FDA’s Center for Drug Evaluation and Research that shows some interesting trends in enforcement. By Douglas B.

Dosage 52
article thumbnail

Episode 575: Novel dosage forms that should not be crushed (but look like they can be)

Pharmacy Joe

In this episode, I’ll discuss novel dosage forms that should not be crushed but look like they can be. Episode 575: Novel dosage forms that should not be crushed (but look like they can be) Subscribe on iTunes , Android , or Stitcher Two relatively new dosage form technologies are nanocrystals and amorphous solid dispersions.

Dosage 40
article thumbnail

Titanium dioxide (E171) and its role in formulation

European Pharmaceutical Review

The ability to uniquely identify oral solid dosage (OSD) forms has been recognised by regulatory authorities worldwide as one of the mechanisms to reduce medication errors and to detect falsified medicines. Changes in the appearance of medicines has been identified as a factor in patient compliance and, therefore, clinical outcomes.

Dosage 98
article thumbnail

QA of prostaglandin analogues for glaucoma treatment

European Pharmaceutical Review

Developments need to be made to enable lower dosages and toxicity, limit adverse effects and find better treatment efficacy of ocular drugs, it stated. A key challenge discussed is active pharmaceutical ingredient (API) impurity profiling in finished dosage forms. The paper by Asendrych-Wicik et. analogues to treat glaucoma.

Dosage 98